Riskpilot← Back to searchSign inGet full accessNarva Åderbråckscenter AB
ABActiveOrg 5590444013Narvavägen 30Medical specialists activities · NACE 8622Est. 201510-19 employees
Revenue 2024
SEK 36,8M
+5% vs 2023
EBITDA margin
7.0%
-27% vs 2023
Equity ratio
38.6%
Financial strength
Net profit 2024
SEK 229K
-73% vs 2023
| Revenue | SEK 36,8M | +5% |
| EBITDA | SEK 2,6M | -27% |
| Net profit | SEK 229K | -73% |
| Total assets | SEK 6,1M | +14% |
| Equity | SEK 2,4M | +11% |
| Employees | — | — |
Legal name
Narva Åderbråckscenter AB
Org number
5590444013
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
23 december 2015
Share capital
SEK 50 000
Employees
10-19
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av Ewerthz, Louise Margareta Johansson Bäckgren, Karl Arne
Company purpose
Aktiebolag ska bedriva medicinsk konsultation och specialistläkarverksamhet samt därmed förenlig verksamhet.
Address
Narvavägen 30
Email
info@narvakirurg.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 31 653 | 28 161 | 31 274 | 34 368 | 37 255 | 35 116 | 36 816 |
| Staff expenses | — | — | — | — | — | — | — | — | — |
| EBITDA | −439 | 9 144 | 7 296 | 4 862 | 3 358 | 3 469 | 1 574 | 3 575 | 2 593 |
| Depreciation & amort. | −58 | −529 | −529 | −529 | −537 | −513 | −237 | −484 | −485 |
| EBIT | −497 | 8 615 | 6 767 | 4 333 | 2 821 | 2 956 | 1 337 | 3 091 | 2 108 |
| Net financials | — | — | −7 | — | −5 | −4 | −16 | — | 69 |
| Profit before tax | 5 503 | 5 545 | 5 261 | 2 864 | 2 116 | 6 491 | 1 321 | 1 091 | 426 |
| Tax | −1 212 | −1 236 | −1 173 | −622 | −467 | −1 388 | −283 | −239 | −197 |
| Net profit | 4 291 | 4 309 | 4 088 | 2 242 | 1 649 | 5 103 | 1 038 | 852 | 229 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 14 447 | 15 724 | 17 453 | 18 414 | 14 664 | 13 655 | 5 808 | 5 334 | 6 081 |
| Equity | 4 341 | 8 650 | 12 738 | 13 779 | 7 127 | 11 230 | 1 268 | 2 120 | 2 350 |
| Long-term debt | 5 105 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 001 | 5 204 | 2 846 | 1 796 | 3 998 | 2 424 | 4 540 | 3 213 | 3 731 |
| Total debt | 10 106 | 5 204 | 2 846 | 1 796 | 3 998 | 2 424 | 4 540 | 3 213 | 3 731 |
EBITDA margin
7.0%
This company
15.8%
Market median
-56% vs market
20162024
Equity ratio
38.6%
This company
38.2%
Market median
+1% vs market
20162024
Return on equity
9.7%
This company
18.4%
Market median
-47% vs market
20162024
Net profit margin
0.6%
This company
8.1%
Market median
-93% vs market
20162024
Asset turnover
6.05×
This company
1.12×
Market median
+440% vs market
20162024
Debt / equity
1.59×
This company
0.62×
Market median
-156% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-11-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AL Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
UC Audit | Audit | 2020 | — | — |
AG Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2026 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2026 | — | — | |
| Chairman | 2022 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Atleva Specialistvård AB | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Atnotera ABAtleva Specialistvård Intressenter ABAtleva Specialistvård AB
Narva Åderbråckscenter AB (this company)Board members of Narva Åderbråckscenter AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alexandra Lena Birgitta Leiderby | Chief Executive Officer | 0 companies |
| Ulla Carina Öfors | Audit | 0 companies |
| Anna Gabriella Hermansson | Chief Auditor | 0 companies |
| Stefan Helge Jacobson | Board of Directors | 0 companies |
| Anders Kahr Törring | Deputy Board Member | 0 companies |
| Sara Helena Karlin | Board of Directors | 0 companies |
| Louise Margareta Ewerthz | Deputy Board Member | 0 companies |
| Johan Jacob Michael Eriksson | Board of Directors | 0 companies |
| Karl Arne Johansson Bäckgren | Chairman | 0 companies |
| Jim Mauritz Johansson | Board of Directors | 0 companies |
| Ralph David Riber | Chairman | 0 companies |
| Matilda Maria Axlind | Deputy Board Member | 0 companies |
| Jan Stefan Nydahl | Chairman | 0 companies |